Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma - Deng, Chuangzhong; Xu, Yanyang; Fu, Jianchang; Zhu, Xiaojun; Chen, Hongmin; Xu, Huaiyuan; Wang, Gaoyuan; Song, Yijiang; Song, Guohui; Lu, Jinchang; Liu, Ranyi; Tang, Qinglian; et al. (Cancer science, 2020)
Keywords: Antibodies; Apoptosis; Automation; Biopsy; Bone cancer; Cancer therapies; CD3 antigen; CD8 antigen; Chemotherapy; CIBERSORT; Clinical trials; Gene expression; Histocompatibility antigen HLA; Immune status; Immunohistochemistry; Immunotherapy; Lymphocytes; Lymphocytes T; Macrophages; Medical research; neoadjuvant chemotherapy; Original; Osteosarcoma; Patients; PD-L1 protein; Ribonucleic acid; RNA; Sarcoma; Studies; Tumors; tumor‐infiltrating immune cells; tumor‐infiltrating lymphocytes; tumor-infiltrating immune cells; neoadjuvant chemotherapy; tumor-infiltrating lymphocytes; CIBERSORT; osteosarcoma